ATL1102 wonder drug; my best guess after reading this ann again, must be a few bucks in selling one or two for that non dillutive outcome.
1. Diabetes
2. Asthma
3. Alzheimers
4. MS
5. DMD
6. Leukemia
7. Steroids
anyone want to add or subtract?
Cant wait for ANP to put these indications in their pipeline graphic.
Ann: New data supports ATL1102s broader clinical potential, page-67
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.3¢ |
Change
0.004(5.80%) |
Mkt cap ! $65.81M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.3¢ | 7.0¢ | $16.42K | 231.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.3¢ | 63510 | 1 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.2¢ |
Change
0.004 ( 2.86 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.2¢ | 7.0¢ | 38700 | ||
| Last updated 13.48pm 01/05/2024 ? | |||||
| PER (ASX) Chart |